ArticleDEN open2027
Feasibility and Safety of a Novel Pig-tail Inside Stent for Unresectable Malignant Hilar Biliary Obstruction: A Single-center Case Series (With Video).
Article in DEN open, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Inside stents are increasingly used for malignant hilar biliary obstruction because of their prolonged patency and removability. Although reported migration rates vary, migration remains a clinical concern, and deployment in angulated bile ducts can be technically challenging. We evaluated a novel pig-tail type inside stent (X-FLEX ARC type) in unresectable malignant hilar biliary obstruction. Methods: This retrospective single-center case series included consecutive patients who underwent X-FLEX ARC type placement between October 2024 and December 2025. Procedural characteristics were evaluated for the 26 deployed ARC-type stents, whereas clinical outcomes were evaluated after the 13 initial drainage procedures. Results: Eighteen patients underwent 21 endoscopic retrograde cholangiopancreatography sessions, during which 26 ARC-type stents were deployed. Deployment into the intended bile duct branch was completed in all selected sessions. The median placement time was 4.0 min, and additional maneuvers were required for five stents (19.2%). Among 13 initial drainage procedures, clinical success was achieved in 11 (84.6%), and no procedure-related adverse events occurred. Recurrent biliary obstruction (RBO) occurred after five procedures (38.5%), with a median time to RBO of 167 days (95% confidence interval, 137-not reached). No ARC-type stent migration was observed. Conclusions: This preliminary case series provides descriptive information on ARC-type inside stent placement and removability in selected patients with unresectable malignant hilar biliary obstruction. Prospective comparative studies are needed to determine its technical applicability and effects on stent migration and long-term patency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.